Chitra Kotwaliwale
Chitra Kotwaliwale is a product executive trained in cell biology. She worked as a computational biologist at Adaptive Biotechnologies before moving into product roles at Complete Genomics and Agilent Technologies. She joined Natera in 2019 and later became its chief product officer.
Contents6 sections
Key facts
Early education: Biology and cell research
Kotwaliwale earned a bachelor’s degree in biology at the College of Wooster. She subsequently earned her doctorate in molecular and cell biology through the University of Washington and Fred Hutchinson Cancer Center.[1]
From 2008Postdoctoral research at Berkeley and industry roles
Her postdoctoral work at UC BerkeleyUniversity of California, BerkeleyThe University of California, Berkeley (UC Berkeley) is a campus of the University of California system; the University of California was founded in 1868 through a merger of two institutions and moved to Berkeley, California, in 1873.Open the full entry received support from the Damon Runyon Cancer Research Foundation and the Howard Hughes Medical Institute. The foundation’s awards register gives her name as Chitra V. Kotwaliwale and dates her award to 2008. She went on to work as a computational biologist at Adaptive Biotechnologies, senior product manager for sequencing at Complete Genomics and director of product marketing at Agilent Technologies, managing a team responsible for rare disease and oncology products.[1][2]
From 2019Product leadership at Natera
Kotwaliwale joined Natera in 2019. She managed products in its women’s health business, coordinated company strategy and project planning across engineering and research, and worked on global product strategy. Her title at the time of her 2024 interview was senior vice president of portfolio management and operations. She later became chief product officer.[1][3]
November 21, 2024Discussing resource allocation
On Crucible Moments, Kotwaliwale explained that Natera’s established women’s health business still needed to reduce testing costs while it invested in oncology. Choosing how much to devote to existing products and new ones was a continuing problem. To illustrate growth, she estimated that Signatera processed only a few thousand samples in all of 2019, compared with more than 100,000 in the first quarter of 2024 alone.[3][4]
Related Organizations, Websites and Public Accounts
Natera: Chief product officer. Official website: https://www.natera.com/ (opens in a new window).[1]
LinkedInLinkedInLinkedIn is a social networking platform for professionals. It was founded in 2002 by Reid Hoffman and others, launched in 2003, and listed on the New York Stock Exchange in 2011; after Microsoft acquired it for approximately $26.2 billion in 2016, it became a wholly owned Microsoft subsidiary. Its revenue comes from membership subscriptions, advertising, and recruitment solutions.Open the full entry: https://www.linkedin.com/in/chitra-kotwaliwale (opens in a new window).[5]
Sources5 sources
- Leadership Team: Matthew Rabinowitz, Ph.D. (opens in a new window)natera.com↑
- Damon Runyon Cancer Research Foundation Awardees, K–P (opens in a new window)damonrunyon.org↑
- Natera ft. Matthew Rabinowitz: A Personal Mission That Led to a Biotech Revolution (opens in a new window)sequoiacap.com↑
- Natera ft. Matthew Rabinowitz - A Personal Mission That Led to a Biotech Revolution (opens in a new window)youtube.com↑
- Chitra Kotwaliwale, Ph.D. (opens in a new window)linkedin.com↑